← Open Payments lookup

STEVEN BRIA: Open Payments

NPI 1215672308 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,153 in 51 payments from 13 companies in 2025. Trend: 2023 $1,487 · 2024 $1,990 · 2025 $1,153

Food & beverage: $1,153
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$211
Neurocrine BioSciences, Inc.6$157
Lundbeck LLC7$155
Janssen Pharmaceuticals, Inc5$127
E.R. Squibb & Sons, L.L.C.5$98
Teva Pharmaceuticals USA, Inc.5$96
Axsome Therapeutics, Inc.3$77
Alkermes, Inc.2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
ABBVIE INC.3$47

Products named: REXULTI, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, COBENFY, Auvelity, UZEDY, ABILIFY ASIMTUFII.

Industry payments across AL — which companies pay providers there.